神経性糖尿の英語

薬効が高く副作用が少ない糖輸送増強作用剤、血糖降下剤、糖尿病、糖尿病性末梢神経障害、糖尿病性腎症、糖尿病性網膜症、糖尿病性大血管症、耐糖能異常、または肥満症の予防および／または治療薬。例文帳に追加

To provide a glucose transportation potentiating agent, a hypoglycemic agent and an agent for the prevention and/or treatment of diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinosis, diabetic macroangiopathy, glucose tolerance failure or obesity and having high drug effect and low side actions. - 特許庁

縮合多環式化合物または製薬学的に許容されるその塩を有効成分とする、糖輸送増強作用剤、糖尿病、糖尿病性末梢神経障害、糖尿病性腎症、糖尿病性網膜症、糖尿病性大血管症、耐糖能異常、または肥満症の予防および／または治療薬。例文帳に追加

The sugar transportation enhancing agent and a prophylactic and/or a therapeutic agent for diabetes, diabetic peripheral neuropathy, diabetic nephritis, diabetic retinopathy, diabetic arteriosclerosis, impaired glucose tolerance or obesity comprise the condensed polycyclic compound or its pharmaceutically permissible salt as an active ingredient. - 特許庁

糖尿病性神経障害の改善、特に糖尿病に罹患している患者の神経伝達速度及び神経血流量を改善するスタチン薬の新しい使用法を提供する。例文帳に追加

To provide new use of a statin drug in the improvement of diabetic neuropathy, particularly in improving nerve conduction velocity and nerve blood flow in patients suffering diabetes. - 特許庁

肥満、糖尿病、不安、抑うつ、神経変性または炎症性疾患の治療または予防法の提供。例文帳に追加

To provide a method for treating or preventing obesity, diabetes, anxiety, depression, neurodegeneration, or inflammatory diseases. - 特許庁

血管周皮細胞の保護作用を示すことにより、糖尿病性網膜症、糖尿病性神経障害、糖尿病性腎症等の予防及び治療に有効な周皮細胞保護剤を提供すること。例文帳に追加

To obtain the subject protecting agent capable of manifesting protecting actions on vascular pericytes and useful for the prophylaxis and treatment of diabetic microangiopathy such as diabetic retinopathy, diabetic neuropathy or diabetic nephropathy by including a prostanoic acid derivative as an active ingredient. - 特許庁

肥満症および肥満によって誘発される高脂血症、脂肪肝ならびにインスリン抵抗性に基づくと考えられる耐糖能異常、糖尿病、糖尿病性合併症（糖尿病性末梢神経障害、糖尿病性腎症、糖尿病性網膜症、糖尿病性大血管症など）、高血圧および動脈硬化症の治療に有効なACC活性阻害阻害剤を提供すること。例文帳に追加

To provide an ACC activity inhibitor which is effective for treating obesity, hyperlipemia induced by obesity, abnormal glucose tolerance thought to be based on fatty liver and insulin resistance, diabetes, diabetic complications (diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy and the like), hypertension, and arteriosclerosis. - 特許庁

肥満症および肥満によって誘発される高脂血症、脂肪肝ならびにインスリン抵抗性に基づくと考えられる耐糖能異常、糖尿病、糖尿病性合併症（糖尿病性末梢神経障害、糖尿病性腎症、糖尿病性網膜症、糖尿病性大血管症）、高血圧および動脈硬化症の治療に有効なACC活性阻害剤またはそれを用いた治療法の提供すること。例文帳に追加

To provide an ACC activity inhibitor which is effective for treating hyperlipemia induced by obesity and fatness, impaired glucose tolerance estimated to be based on fatty liver and insulin resistance, diabetes, diabetic complication (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic great vessel disease), hypertension, and arteriosclerosis, and to provide a therapeutic method using the same. - 特許庁